Medical product and drug distributor Cardinal Health, Dublin, OH, is restructuring to cut costs and realign resources.
 
With the changes the company reduces its workforce by 600 positions. Of those positions, 160 are open and will not be filled.
 
Cardinal’s network of pharmaceutical and medical product distribution centers and nuclear pharmacies will form the Healthcare Supply Chain Services segment, which will have revenues of more than $80 billion.
 
Products for infusion, medication dispensing, respiratory care and infection prevention will be grouped in the Clinical and Medical Products segment with annual revenue of $5 billion.
 
Through this restructuring, we sharpen our focus on two distinct, large and growing segments of the health care industry by aligning our resources, reducing costs and helping to speed decision-making for our customers,” said R. Kerry Clark, CEO.
 
“In fiscal 2009, we remain committed to the turn-around of our pharmaceutical supply chain business, as we continue to strengthen our medical supply chain business, invest in an innovative pipeline of clinical products and ensure we have strong regulatory compliance programs in place across the company. We will also continue to optimize our portfolio to strengthen the core business.”